These lab-created solutions were not developed with leisure use in mind. Within the 1990s, John W. Huffman plus a workforce of fellow chemists at Clemson University created several of the initial formulation for artificial cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts of canna